Infertility in the older woman

Clinical Obstetrics and Gynecology

Volumn 41, Issue 4, 1998, Pages 940-950

  Schmidt Sarosi, Cecilia ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN;

BREAST CANCER; CANCER RISK; ESTRADIOL BLOOD LEVEL; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; HORMONAL REGULATION; MENOPAUSE; OOCYTE DONATION; OVARY CANCER; OVARY FOLLICLE DEVELOPMENT; OVULATION INDUCTION; PREGNANCY RATE; REVIEW;

CLIMACTERIC; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INFERTILITY, FEMALE; MATERNAL AGE; MIDDLE AGED; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; REPRODUCTIVE TECHNIQUES;

EID: 0032453293     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199812000-00020     Document Type: Review

References (58)

1. Speroff L, Glass RH, Kase NG. Clinical gynecologic endocrinology, 5th ed. Baltimore: Williams and Wilkins, 1994.
2. Tietz C. Reproductive span and rate of reproduction among Hutterite women. Fertil Steril. 1957;8:89-97.
3. Spira A. The decline of fucundity with age. Maturitas. 1988;Supp 1:15-22.
4. Schwartz D, Mayaux MJ. Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermic husbands. Federation CECOS. N Engl J Med. 1982;306:404-406.
5. Virro MR, Shewchok AB. Pregnancy outcome in 242 conceptions after artificial insemination with donor sperm and effects of maternal age on the prognosis for successful pregnancy. Am J Obstet Gynecol. 1984; 148:518-524.
6. Warburton D, Kline J, Stein Z, Hutzler M, Chin A, Hassold T. Does the karyotype of a spontaneous abortion predict the karyotype of a subsequent abortion? Evidence from 273 women with two karyotyped spontaneous abortions. Am J Hum Genet. 1987;41: 465-483.
7. Michaeli G, Fejgin M, Ghetler Y, Ben Nun I, Beyeth Y, Amiel A. Chromosomal analysis of unfertilized oocytes and morphologically abnormal preimplantation embryos from an in vitro fertilization program. J Reprod Med. 1990;7:341-346.
8. Munne S, Lee A, Rosenwaks Z, Grifo J, Cohen J. Diagnosis of major chromosome aneuploidies in human pre-implantation embryos. Hum Reprod. 1993;8:2185-2191.
9. Schmidt-Sarosi C, Schwartz LB, Lublin J, Kaplan-Grazi D, Sarosi P, Perle MA. Chromosomal analysis of early fetal losses in relation to transvaginal ultrasonographic detection of fetal heart motion after infertility. Fertil Steril. 1998;69:274-277.
10. Zhang J, Grifo J, Blaszczyk A, et al. In vitro maturation of human preovulatory oocytes reconstructed by germinal vesicle transfer. The 53rd Annual; Meeting of the American Society for Reproductive Medicine. Cincinnati, Ohio. October 1997.
11. Santoro N, Schmidt CL. Pregnancy after an unsuccessful oocyte donation cycle. Fertil Steril. 1990;53:174-176.
12. Sauer MV. Spontaneous pregnancy in women awaiting oocyte donation. J Reprod Med. 1995;40:630-632.
13. Toner JP, Philput CB, Jones GS, Muasher SJ. Basal follicle stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril. 1991; 55:784-791.
14. Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. J Clin Endocrinol Metab. 1990;71:1525-1530.
15. Scott RT, Hofmann GE. Prognostic assessment of ovarian reserve. Fertil Steril. 1995; 63:1-11.
16. Scott RT, Leonardi MR, Hoffmann GE, Illions EH, Neal GS, Navot D. A prospective evaluation of clomiphene citrate challenge test screening in the general infertility population. Obstet Gynecol. 1993;82:539-545.
17. Burger HG. Diagnostic role of follicle-stimulating hormone (FSH) measurements during the menopausal transition-an analysis of FSH, oestradiol and inhibin. Eur J Endocrinol. 1994;130:38-42.
18. Scott RT, Hofmann G, Oehninger S, Muasher SJ. Intercycle variability of day 3 follicle-stimulation quality in in vitro fertilization. Fertil Steril. 1990;54:297-302.
19. Magarelli PC, Pearlstone AC, Buyalos RP. Discrimination between chronological and ovarian age in infertile women aged 35 years and older: predicting pregnancy using basal follicle stimulating hormone, age and number of ovulation induction/intrauterine insemination cycles. Hum Reprod. 1996; 11:1214-1219.
20. Fujimoto VY, Klein NA, Battaglia DE, Bremner WJ, Soules MR. The anterior pituitary response to a gonadotropin-releasing hormone challenge test in normal older reproductive-age women. Fertil Steril. 1996;65:539-544.
21. Huyser C, Fourie FL, Pentz J, Hurter P. The predictive value of basal follicle stimulating hormone and growth hormone levels as determined by immunofluorometry during assisted reproduction. J Assist Reprod Genet. 1995;12:244-251.
22. SART. Assisted reproductive technology in the United States and Canada: 1995 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril. 1998;69:389-398.
23. Bopp BL, Alper MM, Thompson IE, Mortola J. Success rates with gamete intrafallopian transfer and in vitro fertilization in women of advanced maternal age. Fertil Steril. 1995;63:1278-1283.
24. Nelson JR, Corson SL, Batzer FR, et al. Predicting success of gamete intrafallopian transfer. Fertil Steril. 1993;60:116-122.
25. Abdelmassih R, Sollia S, Moretto M. Acosta AA. Female age in an important parameter to predict treatment outcome in intracytoplasmic sperm injection. Fertil Steril. 1996;65:783-787.
26. Jacobs SL, Metzger DA, Dodson WC, Haney AF. Effect of age on response to human menopausal gonadotropin stimulation. J Clin Endocrinol Metab. 1990;71: 1525-1530.
27. Dodson WC, Haney AF. Controlled ovarian hyperstimulation and intrauterine insemination for treatment of infertility. Fertil Steril. 1991;55:457-467.
28. Agarwal SK, Buyalos RP. Clomiphene citrate with intrauterine insemination: is it effective therapy in women over 35 years? Fertil Steril. 1996;65:759-763.
29. Vollenhoven B, Selub M, Davidson O, et al. Treating infertility: controlled ovarian hyperstimulation using human menopausal gonadotropin in combination with intrauterine insemination. J Reprod Med. 1996; 4:658-664.
30. Hull GR, Fleming CF, Hughes AO, McDermott A. The age-related decline in female fecundity: a quantitative controlled study of implanting capacity and survival of individual embryos after in vitro fertilization. Fertil Steril. 1996;65:783-790.
31. Hodgen GD. The dominant ovarian follicle. Fertil Steril. 1982;38:281-300.
32. Scott RT, Navot D. Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil Steril. 1994;61:880-885.
33. McCulloh D, Klugewicz D, Nachtigall M, et al. Increased incidence of pregnancy when transdermal estradiol is applied during controlled ovarian hyperstimulation using gonadotropins and intrauterine insemination. The 45th Annual Meeting of the Society for Gynecologic Investigation. Atlanta, Georgia. March 1998.
34. Roest J, Van Heudsen AM, Mous H, Zeilmaker GH, Verhoeff A. The ovarian response as a predictor for successful in vitro fertilization treatment after the age of 40 years. Fertil Steril. 1997;66:969-973.
35. Stolwijk AM, Zielhuis GA, Sauer MV, Hamilton CJ, Paulson RJ. The impact of the woman's age on the success of standard and donor in vitro fertilization. Fertil Steril. 1997;67:702-710.
36. Scholtes MC, Zeilmaker GH. Blastocyst transfer in day-5 embryo transfer depends primarily on the number of oocytes retrieved and not on age. Fertil Steril. 1998; 69:78-83.
37. Menezo YJ, Nicollet B, Dumont M, Hazout A, Janny L. Factors affecting human blastocyst formation in vitro and freezing at the blastocyst stage. Acta Eur Fertil. 1993;24: 207-213.
38. Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet. 1995;346:995-1000.
39. Schmidt-Sarosi CL. In vitro fertilization of donor oocytes. In: Keye WR, Chang RJ, Rebar RW, Soules MR, eds. Infertility: evaluation and treatment. Philadelphia: WB Saunders, 1995; 780-787.
40. Sauer MV, Paulson RJ, Ary BA, Lobo RA. Three hundred cycles of oocyte donation at the University of Southern California: assessing the effect of age and infertility diagnosis on pregnancy and implantation rates. J Assist Reprod Genet. 1994;11:92-96.
41. Levran D, Ben-Rafael Z, Ben-Shlomo Z, Nebel L, Mashiach S. Aging of the endometrium and oocytes: observation on conception and abortion rates in an egg donation model. Fertil Steril. 1991;56:1091-1094.
42. Meldrum DR. Female reproductive aging-ovarian and uterine factors. Fertil Steril. 1993;59:1-5.
43. Yaron Y, Botchan A, Amit A, Kogosowski A, Yovel I, Lessing JB. Endometrial receptivity: the age-related decline in pregnancy rates and the effect of ovarian function. Fertil Steril. 1993;60:314-318.
44. Paulson RJ, Hatch IE, Lobo RA, Sauer MV. Cumulative conception and live birth rates after oocyte donation: implications regarding endometrial receptivity. Hum Reprod. 1997;12:835-839.
45. Remohi J, Gartner B, Gallardo E, Yalil S, Simon C, Pellicer A. Pregnancy and birth rates after oocyte donation. Fertil Steril. 1997;67:617-623.
46. Mantzavinos T, Dimitriadou F, Kankas N, Rizos D, Arvaniti K, Voutsina K. Pregnancy results after ovum donation following one to seven embryo transfers. Fertil Steril. 1996;66:765-768.
47. Benshushan A, Schenker JG. Age limitation in human reproduction: is it justified? J Assist Reprod Genet. 1993;10:321-331.
48. Antinori S, Versaci C, Hossein Gholami G, Panci C, Caffa B. Oocyte donation in menopausal women. Hum Reprod. 1993;8: 1487-1490.
49. Borini A, Bafaro G, Violini F, Bianchi L, Casadio V, Flamigni C. Pregnancies in post menopausal women over 50 years old in an oocyte donation program. Fertil Steril. 1995;63:258-261.
50. Flamigni C, Borini A, Violini F, Bianchi L, Serrao L. Oocyte donation: comparison between recipients from different age groups. Hum Reprod. 1993;8:2088-2092.
51. Pantos K, Meimeti-Damianake T, Vaxevanoglou T, Kapetanakis E. Oocyte donation in menopausal women aged over 40 years. Hum Reprod. 1993;8:488-491.
52. Sauer M, Paulson R, Lobo R. Pregnancy after 50: applying oocyte donation to women following natural menopause. Lancet. 1993;341:321-323.
53. Sauer M, Paulson R, Lobo R. Reversing the natural decline in human fertility: an extended clinical trial of oocyte donation to women of advanced reproductive age. JAMA. 1992;268:1270-1275.
54. Rochat RW, Koonin LM, Atrash HK, Jewett JF, and The Maternal Mortality Collaborative. Maternal Mortality in the United States: Report from the Maternal Mortality Collaborative. Obstet Gynecol. 1988;72: 91-97.
55. Sauer M, Paulson R, Lobo R. Pregnancy in women 50 or more years of age: outcomes of 22 consecutively established pregnancies from oocyte donation. Fertil Steril. 1995; 64:111-115.
56. Check JH, Nowroozi K, Barnea ER, Shaw KJ, Sauer M. Successful delivery after 50: a report of two cases as a result of oocyte donation. Obstet Gynecol. 1993;81:835-836.
57. Dean N, Edwards RG. Oocyte donation: implications for fertility treatment in the nineties. Curr Opin Obstet Gynecol. 1994; 6:160-165.
58. Legro SL, Shackleford DP, Moessner JM, Gnatuk CL, Dodson WC. ART in women 40 and over: is the cost worth it? J Reprod Med. 1997;42:76-82.